Interagency Patent Coordination and Improvement Act of 2022
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Interagency Patent Coordination and Improvement Act of 2022
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4430: Interagency Patent Coordination and Improvement Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-S-4430/
"S. 4430: Interagency Patent Coordination and Improvement Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4430/.
S. 4430, 117th Cong. (2026), https://openamerica.io/bill/117-S-4430/.
[S. 4430: Interagency Patent Coordination and Improvement Act of 2022](https://openamerica.io/bill/117-S-4430/)